SAREPTA THERAPEUTICS, INC. Peo Total Comp Amt
SAREPTA THERAPEUTICS, INC. (SRPT) reported Peo Total Comp Amt of $7.84 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-24.
Financial Statements › Notes
ecd:PeoTotalCompAmt · last filed 2026-04-24
| Period end | Peo Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $7.84M DEF 14A · filed 2026-04-24 |
| 2024-12-31 | $1.98M DEF 14A · filed 2026-04-24 |
| 2023-12-31 | $1.66M DEF 14A · filed 2026-04-24 |
| 2022-12-31 | $124.94M DEF 14A · filed 2026-04-24 |
| 2021-12-31 | $1.55M DEF 14A · filed 2026-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |